Gene Editing Technologies to Target HBV cccDNA
Hepatitis B virus (HBV) remains a significant cause of mortality and morbidity worldwide, since chronic HBV infection is associated with elevated risk of cirrhosis and hepatocellular carcinoma. Current licensed therapies against HBV efficiently suppress viral replication; however, they do not have s...
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
MDPI AG
2022-11-01
|
| Saila: | Viruses |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/1999-4915/14/12/2654 |